Delivery Order SPE2DB24D2106-SPE2DB25FAWDB
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,982.46 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lisdexamfetamine 40 mg capsules (100-count units). The contract is a firm fixed-price delivery order with no set-aside designation, reflecting DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. Performance will occur in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on August 4, 2025, for the supply of Lisdexamfetamine 30 mg capsules in quantities of 100. This firm fixed-price delivery order, valued at $1,388.47, is set to be completed by August 5, 2025, with performance taking place in Conshohocken, Pennsylvania. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on equal...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. for Lisdexamfetamine 30 mg capsules (100-count units) on September 12, 2025, with a ceiling value of $2,680.52. This firm fixed-price delivery order, which is expected to be completed by September 15, 2025, represents a continuation of the agency's pharmaceutical supply needs and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was made without a set-aside designation....
- The Defense Logistics Agency awarded a delivery order valued at $2,027.13 to DMS Pharmaceutical Group Inc. for Lisdexamfetamine 70 mg capsules (90-count) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents performance at DMS Pharmaceutical Group's facility in Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,070.16 firm fixed-price contract is for the delivery of 100 units of 40 mg lisdexamfetamine capsules. The contract has an ultimate completion date of March 20, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,281.36 firm fixed-price contract is for the delivery of 100 units of the prescription drug lisdexamfetamine 70 mg capsules. The contract has a completion date of July 9, 2025 and does not have a set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery...
- This is a federal contract award by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a delivery order valued at $1,176.64 for the supply of 4567764395 Lisdexamfetamine 50 mg capsules. The contract has a firm fixed-price pricing type and an ultimate completion date of April 2, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $2,135.88 award is for the delivery of 100 units of 30mg lisdexamfetamine capsules. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, which allows the agency to issue delivery orders for a wide range of pharmaceutical products,...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on July 24, 2025, for Lisdexamfetamine 30 mg capsules (90-count units) with a ceiling value of $1,191.06. This firm fixed-price delivery order represents a specific pharmaceutical supply requirement under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA, valued at $499,999,999 and valid through November 2026. The place of performance is Conshohocken, Pennsylvania. DMS Pharmaceutical Group...
- This is a $1,272.52 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 100 units of 60 mg lisdexamfetamine capsules. This order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the agency to issue...
- SPE2DB24D2106Indefinite Delivery Contract
- SPE2DB24D2106-SPE2DB25FAWDBDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lisdexamfetamine 70 mg capsules (90-count units). The contract, awarded on August 25, 2025, carries a ceiling value of $1,191.75 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 26, 2025. The performance location is identified as Conshohocken, Pennsylvania. This award does not include a set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its woman-owned small business status. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that authorizes the issuance of firm fixed-price orders for a comprehensive range of pharmaceutical products supporting Department of Defense medical supply requirements. DMS Pharmaceutical Group serves as a critical supplier in the federal pharmaceutical supply chain, providing prescription medications and pharmacy services directly to military healthcare facilities nationwide. The company's contract portfolio demonstrates extensive experience delivering branded and generic prescription drugs, biologics, and medical consumables to government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/25/25 |